Optimise mRNA Vaccines for Higher Protein Expression
Artificial Intelligence for Designing mRNAs with High Translational Power
Tags: Australian National University, Australia, Healthcare & Lifesciences
ANU has created a machine learning model to accurately correlate mRNA's translating power with protein synthesis, enhancing understanding of cellular responses. This breakthrough can optimize mRNA vaccines and plasmids for higher protein expression. The technology allows for precise measurement of translational dynamics, offering insights into cell stress, disease, and aging. Applications include plasmid design, vaccine development, and diagnostics. ANU seeks investment for further development and collaborative projects in synthetic biology and therapy.
IP Type or Form Factor: Patent Pending; Trade Secret; Platform; Software & Algorithm
TRL: 5 - prototype ready for testing in intended environment
Industry or Tech Area: Vaccines; Biotechnology
